Profound Medical Corp
TSX:PRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Profound Medical Corp
Gross Profit
Profound Medical Corp
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Gross Profit
$11.4m
|
CAGR 3-Years
56%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Gross Profit
CA$554k
|
CAGR 3-Years
5%
|
CAGR 5-Years
54%
|
CAGR 10-Years
-5%
|
|
|
MedMira Inc
XTSX:MIR
|
Gross Profit
CA$134.9k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-21%
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Gross Profit
$10.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Gross Profit
CA$1.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Gross Profit
$759k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Gross Profit?
Gross Profit
11.4m
USD
Based on the financial report for Dec 31, 2025, Profound Medical Corp's Gross Profit amounts to 11.4m USD.
What is Profound Medical Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
27%
Over the last year, the Gross Profit growth was 62%. The average annual Gross Profit growth rates for Profound Medical Corp have been 56% over the past three years , 27% over the past five years .
